Validation of Clinical Assessment of Spinal Stiffness

Sponsor
Istituto Scientifico Italiano Colonna Vertebrale (Other)
Overall Status
Recruiting
CT.gov ID
NCT05924581
Collaborator
(none)
25
1
1
8.8
2.8

Study Details

Study Description

Brief Summary

This study aims to validate and verify the reliability of the clinical measures used in the daily routine by doctors and therapists that allow assessing the spinal stiffness in all spatial planes. The secondary objective is the verification of the diagnostic accuracy of the most reliable tests in identifying the subjects at risk of failure, using as a radiographic standard the examinations performed by the patients during the treatment (data retrieved retrospectively) using as a control group those patients who did not obtain a correction of the spine curvature.

Condition or Disease Intervention/Treatment Phase
  • Other: Clinical assessment of spinal stiffness
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
25 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Validation of Clinical Assessment of Spinal Stiffness in Hyperkyphosis and Scoliosis During Growth
Actual Study Start Date :
Jun 6, 2023
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Mar 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Clinical assessment of spinal stiffness

Patients' back flexibility will be assessed during the medical examination or physiotherapy session through one of the following non-invasive tests: Thoracic Stiffness Test (TST) Scoliosis stiffness test (SST) Kyphosis Stiffness Test (KST) Each test will be carried out at the beginning of the visit and repeated at the end 2 times by different operators, or once by the same operator to verify that the measurements taken at different times are reliable and that the measurements taken by two different operators are reliable.

Other: Clinical assessment of spinal stiffness
The clinical stiffness tests will be applied twice to the same patient by the same operator to verify intra-operator variability and twice by two operators at the same time to verify inter-operator variability. The verification of diagnostic accuracy with respect to the radiographic reference standard will be carried out retrospectively by using the data already available and systematically collected in electronic format during medical visits and physiotherapy sessions.

Outcome Measures

Primary Outcome Measures

  1. Reliability [through study completion, an average of 6 months]

    Test-retest reliability of the three stiffness assessment tests. Inter class correlation will be calculated

  2. Repeatability [through study completion, an average of 6 months]

    Inter-Rater and Intra-Rater Repeatability of the three stiffness assessment tests

  3. Diagnostic accuracy [through study completion, an average of 6 months]

    diagnostic sensitivity and specificity of each test

Eligibility Criteria

Criteria

Ages Eligible for Study:
10 Years to 17 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Scoliosis > 10°Cobb or Hyperkyophosis >50° Cobb

  • Age between 10 and 17 years old

  • Risser between 0 and 5

Exclusion Criteria:
  • History of spinal surgery

  • Presence of back pain

  • Diagnosis of congenital scoliosis or scoliosis secondary to neurological or muscular diseases

Contacts and Locations

Locations

Site City State Country Postal Code
1 ISICO Milan Mi Italy 20141

Sponsors and Collaborators

  • Istituto Scientifico Italiano Colonna Vertebrale

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Istituto Scientifico Italiano Colonna Vertebrale
ClinicalTrials.gov Identifier:
NCT05924581
Other Study ID Numbers:
  • ClinTest-HKS
First Posted:
Jun 29, 2023
Last Update Posted:
Jun 29, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 29, 2023